PharmaShots | Incisive News in 3 Shots

Subscribe Now

EnteroBiotix

EnteroBiotix Commences the P-II Clinical Evaluation of EBX-102-02 for the Treatment of Irritable Bowel Syndrome (IBS)

EnteroBiotix Commences the P-II Clinical Evaluation of EBX-102-02 for the Treatment of Irritable Bowel Syndrome (IBS)

April 3, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us